![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1406, 2003-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lyseng-Williamson K.A. Perry C.M.
Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Controversy surrounds use of drotrecogin-alfa
Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drotrecogin Alfa (Activated): A Viewpoint by Marcel Levi
By Levi M.
Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drotrecogin-alfa relatively cost effective in severe sepsis
Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drotrecogin alfa improves organ function in severe sepsis
Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. :